Both your's and Longfellow's terms touch a fraction of it. Thanks.

I do like the peacock dance you attached, and the nice words from Longfellow [in brackets].

I also very much like my "peacock dancing" days with vigor, valor and youthfulness.

Life is good, young or old. Had had a dream of buying out all the shares and seeing the price going up into the blue sky.

Suggesting I am still damned young.

I also added measly 10k shares at $0.371 per share this morning. Was intended to buy more on seeing it dropped to around $0.365, and gave it up when the price was back up again.

I had had too many shares but just hated to see it went down unexceptionably at this inflection point.

Someone please comes up with an appropriate term for my action/behavior, like some kind of a syndrome, and I may print out and hung on the wall just behind my main computer.

There should be a lot of liquidity available now in the general market after quarter end rebalancing and profit taking due to gloomy outlook resulted in surging Covid-19 in the US.

If only a tiny part of this liquidity comes to nwbo, we will fly sooner than expected.

GLTA!

New found alliance? LOL we knew it century ago.

At $0.37 per share, and a roughly $260 million MC today. Is this not cheap enough?

Now looking forward

Data lock by end of next week

Topline data by end of next month

By a margin, you are free to move around these goal posts some days further. Regardless, there will be a rude awakening for a lot of heads when all are done soon.

The blinded data just need to be confirmed to be equally good if not better. Then

FDA has no way but to usher in a new age of how cancers will be treated with a new generation, paradigm shift immunotherapeutic cancer vaccines spearheaded by Northwest Bio's DCvax platform.

There is a risk of course, but it is worthy of taking. Many still have the pipe dream to get in cheap when things turn out to be what expected with regard to trial data.

At this point, the usual fearmongers like dilution, financing, and the like don't work any more.

It's appalled that the comprehension and cognition of some posters in this board are so unexplainably low evidenced by their confusion between soft lock and hard lock.

For God sake, the soft lock discussed by the company is such a lock that can yield topline data based on all the critic data necessary, even without some additional data, which may be important but not critic -- the kind of soft data lock meant and mentioned by the company.

So whenever these data sets which are not available at the lock become available, they will be incorporated back the database and locked -- therefore resulting in hard data lock thereafter.

It means the kind of soft data lock even used by the company will not hinder the process to have topline data in a timely manner.

BTW, in modern clinical trials, it has become a common practice for a sponsor company to have a quarterly data lock (soft lock) to be able to analyze data on a quarterly basis and then make timely and knowleged decision on how the underlying trial should proceed. Please don't fall in the trap of the wolfpack, fudsters, and the like.

Sometimes I think some people just don't spend time to read but eager to post. Are those people real investors?

Right the company has not burdened itself for announcing DL, hard or soft, only committed update if the company has missed its estimated DL in a significant way. As for Topline data, no commitment yet as it is conditioned on DL.

So it is very likely the company may not publish its DL despite contrary to some posters who have reported otherwise from their communications with DI.

As a result, any day passes without news may not be a bad news, and particularly any day passes without news after July may be a good sign, or an indicative of a positive TL data readout.

No post left for me today. GLTA!

Yes you are right Sharkee2, and I will not bother.

Although I asked those Qs to this board, I had had the answers if not all in the form of my humble opinions of course.

So I don't think Linda by any means is incompetent, but greedy maybe; I think the communications as it has been over the years and now is intentional, thinking it's good for the company overall, which can only be understood in the future.

She has to be sneaky and hold things tight to her chest as she has only this chance, to either die or prosper.

If she can get it right this time for DCVax-L, all will forgiven and what will be said about is her valor, and her and ours victorious human endeavor in conquering the deadliest cancers with a huge return of capitals invested.

So regardless at least waiting!

If I think any message chatter has any impact on share price then I should not post this before I load some more shares this afternoon. No I don't. Here it goes:

After years upon years over-promise & under-deliver does she learn a thing or two? Why hasn't she used a cushion in her timeline estimation yet, as that is any human alive will do in forecasting timeline? Or is there something else besides the German tax issue, and damned Covid-19?

Is it the culprit that Linda fails to slit the pot for the deserved employees and consultants and anyone signed for it, which seems very unlikely as Linda always has had the power of a dictator so no one dares to say no?

Additionally, what happens to twice delayed DL and Topline Data timeline? Besides the excuses specified by the company, again is there something else that hinders.

Could the culprit really be something about/on Dr. Duffy who left the company during the quarter after a short stint of a frigging 7-month employment with the company when the long-delayed SAP was finally successfully complete? Is it really some sort of an agreement or consensus or MoU that was materialized during the quarter between NWBO and MRK that is the culprit for still yet to be delivered 10Q and data timeline, so that dragging a bit longer may solve the problem?

And is the agreement or MoU contingent or simply conditioned on what will be the results of the topline data? Should the company just go ahead to file 10Q while ignoring the existence of such an agreement or MoU, and acknowledge its pre-existence afterward?

Can the filing of 10Q now hinder the on-going negotiation if indeed existing between the two companies over some more concrete or specific terms on top of the MoU as topline data are almost on hand? Should such a negotiation better limit to only Linda and/or Les in NWBO's side, and in order to do that Ms. Davis better relinquished her role as CFO to Linda?

As of today, longs have been frigging long the stock multiple years if not longer, and have done their DDs and fortified regardless so that waiting for the topline data is the only game despite seemingly setbacks.

On the other hand, there are definite signs of cracks that have emerged on the other side of the bet, which seeing share price suddenly spiked from about 0.16 to over 0.40 in days, then coming back down a bit, during which time most if not all of the set to expire warrants seem to have exercised from those unfriendly who have repeatedly shorted the stock, got cheaper shares in expected financing deals repeatedly over the years, with newly issued warrants as their hedges.

Sniff dogs are out, SEC is burdened, the delinquent report is still delinquent, and the fulfillment of data timelines has yet to report.

What gives? Is Linda Powers really inferior to a street Joe in forecasting and doing her job, or is she a grandmaster chess player?

Even a Broken Clock Is Right Twice a Day

DATA LOCK -- IMMINENT
TOPLINE DATA -- WITHIN A MONTH!

For an ordinary clock, more to come.

Excerpt from company June 2 PR:

"In light of the current status of the completion process, and the experience over recent months, the Company currently anticipates that the process may be completed by about mid-June or shortly thereafter –" and

"The timing of such processes cannot be predicted with precision even in normal times, and especially not in the current unprecedented circumstances. However, the Company and the independent service firms that are carrying out these processes are committed to proceeding quickly. If the anticipated timing becomes significantly different than currently anticipated, the Company plans to provide additional update bulletins."

They are still on track as of today.

[Again not intended in reply to 2H2]

The projected Goals were posted just two weeks ago, The paint has yet to dry. So don't go astray and stay in course:

Data lock imminent
Topline data within a month

In the meantime, the stock, though appreciated substantially from $0.17 to $0.37 in the past month, is as cheap as a mopping cloth judged by the market potential of the underlying DCVax Platform, and the meager market cap of nwbo now well below $300 million.

If topline data are positive, the projected market cap would be tens or twenties of billion -- an equivalence of share price of $10 - $20 per piece.

All Quiet on the Western Front

[not intended as a reply to pphmlover]

tryn2 My statement is based on the situation we are in now, low share price in relation to the relatively low market cap.

I guess it mostly will depend on market cap. If share price is overly depressed as of it's today, the price will definitely overshoot when positive topline data are announced; on the other hand, if share price appreciates substantially with the waiting period up to topline data announcement, it may and may not have an overshoot, all depending on what market cap one would expect on what results of the topline data will be.

It's very hard or almost impossible to predict exactly how the price movement would be in general considering there are other myriad factors in play as well.

I recalled DNDN's share price crashed in a short period of time, I remembered in that morning when the company announced its confirmatory second p3 trial results, and the results are positive. I was stun seeing the positive results and the crashed share price, but believed it was a major short attack manipulation after some search in the Internet for potentially missed negative news, which was none.

So one would never know and the fact is that anything could happen. Nonetheless, one can certainly predict the general trend. In our case, if the trial results are what we expect, the share price would be heading in a course of major appreciation or correction, but the road ahead may not be as clear as we hope for. Regardless, the price will after a certain period of time correlate to a reasonable market cap.

So one should draw some lines of market cap expectations to weigh in on actions from time to time, either to add or unload some shares based on the changing situations and ones own risk tolerance level.

Just my two cents.

Jerry I know that's all you have got. Man you never change, neither your position whatever what that is.

The reckoning is coming after a long 10 to 12 years of getting the truth out for DCVax-L, that it will become a very effective treatment and SOC for GBM patients. Regardless what the past is, topline data within a month!

And that's not all because it will open the door for how all kinds of solid cancers will be treated in the future.

So count the days together with us long investors, and congratulate on us long investors in advance, because I know being a human after work Jerry you have run the numbers too based on published blended data sets.

I promise DCVax platform will not discriminate you in case you need it in the future, despite your past unfortunate dispositions, destructiveness and negativity against it.

We are humans Jerry and we ought to pardon you!

I think we are talking the same, with difference being that I think it's a common sense that nwbo should and ought to come up with a "completely new SAP" for an almost "completely new test matrix," which is not to test merely PFS, mOS/OSs as designed for a short-term (my 400m, 800m analogy run) test, but to also and most importantly test long-term OSs, such as landmark 3-, 4- and 5-year OSs (my marathon analogy).

So the previous SAP becomes irrelevant, and it must be rewritten. In a sense the current SAP should be regarded as it's an "original" SAP.

In many occasions, both Lindas and Bosch have said the trial has adaptable design, and I don't think it will be any difference otherwise since the trial will produce long-term data. If we indeed see around 20% 5-year survival rate the SAP must be able to capture and accommodate that in an undeniable way.

And I strongly believe FDA holds the same view too as it is evidenced in its March proposal, and our future BLA when submitted will be evaluated by FDA in a new way as it has proposed, because that's the only scientific way to measure it.

It is a common sense that the current SAP is the first.

If a trial is to test human strength in running, the initial test design of DCVax-L is to test 400m or 800m as it had been usually done with chemo drugs, an old fashion way, and an obsolete test matrix for immuno drugs/agents/vaccines that we have all well understood today. Now it's all known the best way to test/measure is to run a marathon instead -- a 42.2 km long running.

Today nobody thinks a good result of 400m or 800m run (test) would indicate/correlate a good result of a marathon run. So mOS in cancer vaccine test is obsolete and useless in measuring OS for cancer patients.

Nobody would think the measurement matrix (SAP in our case) for 400m and 800m running (tests) would be the same SAP (test measurements) for a 42.2 km long marathon run.

Therefore, there are no tweaks or tricks naturally in changing a matrix (SAP) initially designed for a short distance run (immuno test with chemo test measurement matrix) to a matrix (SAP) of a marathon run (immuno test).

So in my book, the current SAP is the first of its kind. I would not even call it revised, because nothing there need to be revised, and it's all pioneering, genuine and original.

And the wolfpack don't think that way, I believe FDA would think the same as I stated above.

BTW, today nwbo's market cap at the present is still below $250 million, and a share price per share of about $0.36.

Does it reflect its potential which will be known within a month?

Obviously it's a typo. It should be $0.3382

[just saw ex reply on my behalf, and he is correct. Actually I just check again the last batch filled for me is not 6k I intended, it's actually only 5.1k. I don't know why, but I don't care for such trivial. Good luck]

[DATA LOCK NEXT WEEK !!!!!!

TOPLINE DATA NEXT MONTH !!!!!!!]

Just for record, I have done buying today with the last bath about 6k shares at 0.382 filled a few minutes ago in two lots. Feel great and now going to have a nap, and then heading to the river for some summer fun.

Good luck and have a good weekend!

In GBM, the standard of cares (SOC) have yielded dismal prospects/results for patients with OS around 15-18 months;

Nothing significant has been achieved over the past decades.

miraculously and mysteriously, the electric hat Optune (nvcr) had seen its controlled short live SOC, and succeeded with FDA approval for unexplained MOC and OS advantage;

All the failed pivotal P3 trials, including imuc, cldx, etc, haven't seen their control patients outlive SOC anymore significantly.

And most importantly, all P3 trials conducted so far for GMB failed, and have failed to yield any long term survival data. They usually stopped follow patients either prematurely or intentionally at convenient time. Never ever give actual long-term survival data.

On contrary, DVCax-L has promising survival data published in blended manner, and based on the above, it is already a success. On top of that, the suggested long-term survivals if confirmed will be unprecedentedly and unbelievable good.

Nobody will deny that a patient having about 35% and 20% chances of living over 3 and 5 years is not a wonderful thing in the dreaded treatment landscape of GMB.

In term of stock, $250 million market cap, and $0.34 per share is the current situation.

Buy or not, you are smart guys. Make your own decision!

[sorry sukus this post was not intended to reply to yours. instead it was intended for a stand alone one]

We shall see if topline data is positive that how share price behaves. For the legally shorted tiny 8 or 10 million shares, it will not do much to substantial rise of share price so if we see otherwise

Actually there are more naked shorts with nwbo because nwbo is trading in OTC thus it's wild wild land there is not sheriff, and its share price is so pennies that nobody is serious to borrow or lend shares to borrowers, or simply it's infeasible to illegally short the stock as other normal stocks. The ones that are naked shorting the stock are MMs, major brokerage houses, a few big sharks that have the backing of some major brokerage with a long profitable relationship that they have mutually developed over years.

The motives of all this is of course to make money. According to statistics models, more than 50% of times the do make money by shorting development stage biotech companies, particularly on the eve of a binary event. It's as simple as that, let alone with a company with too many controversies like nwbo with a CEO with bad reputation like Linda.

So they naked shorts, carry and shift the deficit along in a flowing book manner, aided by so-called reg exemptions if SEC or anyone dares or is interested in having a look at their books.

Linda understands this very well judged by her action regarding suspension of almost 300 millions of potential shares worthy of warrants and options until November.

So in case the trial data are positive. They will try myriad tricks to cover their faked naked short scheme, eg, from about $0.5 all the way to $5, or even $15 at the peak, and then as investors unload shares to lock profit, they can finally cover all their asses in a range of about $3 -$6.

After that the same actors would play the role of longs, pumpers, and the price will continually rise.

Net net they will still make money so it's a perennial winning strategy if anything or most of things goes by their play books.

This is obviously part of penny stock investing in North America. I have known this for a long time.

BTW I bought yesterday as promised, and intend to buy today as well. I expect stock price will start rise maybe later today or tomorrow as data lock announcement is imminent.

Thanks sukus, you are one of the great posters here. This is my last post today, and off to a walk along the river.

Get dry powder ready and will buy more in case the price heads south, and will buy even more, much more shares if topline data are positive.

As I am typing I see price heading south a bit so I may delay my walk before I add some more.

GL

Andy please keep up the great work to counter and crash those Fudsters. You are 100% accurate to the Fudsters, even though a few misfires at the friendlies.

Thanks, and yes I believe the wall of $0.42 will be readily broken in anticipation or when data lock is announced in a few trading days.

I added yesterday, and may add more today if the price goes south.

Besides the usual wolfpack who work hard tonight to demoralize the spirit of investors by injecting FUD, it seems some sour grapes also pop up -- crying for cheaper shares. In fact, anyone wants them, but the time is the past!

Nothing will change that the company will lock data by the Mid of June and announce topline data by the mid of July.

After that, a paradigm shift cancer treatment platform will see its first fruit of outstanding pivotal Phase III DCVax-L trial results for treating GBM, one of the toughest to treat cancers by the mid of July.

Then, there will be broad lights for treating other solid cancers as the approval of concept for DCVax platform is in the card with outstanding DCVax-L results.

Men, bet on it. It's coming. Today's $0.37 will be multiple dollars in short term, and teens, twenties in mid term!

BTW, Andy we need you.

Thank you Andy2018 for your tireless and timely rebuttals to those one or two line proliferate posters who have cluttered the board for so long with never ending negativity, and to those who seem to have nothing else to do but post lengthy boring off-topic stuff such as anything covid, etc., IN THEIR OWN WAYS, the ways the can understand.

You are the man. You have beaten them all!

People should always remember:

According to the company, by the mid of June data lock will be effected, and by the mid of July topline data will be announced.

The market cap now is only about $260 millions with share price at about $0.37, what will/should the cap be after topline data for an effective treatment for one of the deadest cancers with no side effects?

In the meantime, we should ignore all others which are just noise.

Thank you again for constantly watching them and beating them in their own ways.

I am buying today as not many leaves have been able to be shaken by the wolfpack and within a week time we will be able to see 10Q and most importantly data lock, not soft one but a hard data lock.

I don't think Linda Powers brain is so little that she might miss twice the target for data lock.

Then, in about one month, we will have topline data.

Compared to the major events like data lock and topline, all others are just noise at this time!

[Sorry I am competing with shares with both long and short]

Delayed 10Q due to a German tax issue, Is it a cover for something substantial, not a few million research fund or operating loss incurred, but something like a deal in the making with German Merck-Merck KGaA.

Perhaps a licensing deal with Merck KGaA for Germany and/or whole Eu, excluding UK.
Perhaps a partnership deal with KGaA ...

All subjected to a peek at the results in about one month of time.

Judged by the unprecedentedly long delay, perhaps the underlined German tax issue is just an argot for a collaboration deal in the making?

[Note: Merck KGaA's glioblastoma candidate cilengitide failed in Ph III study treating GBM in early 2013]

Granted, the primary endpoint PFS may well meet its target ss after adjudication, the focus still should be focused on overall survivals, particularly of the fact that now we have had actual hard long-term data, not those in other trial: projected or curve-derived data for long-term.

After all, PFS is just a surrogate for os.

[It seems I can have more than one post a day! Thanks]

To be noted that

1) the alphapuppy's modeling may look as good and persuasive as a lot investors would think with regard to PFS, common sense indicates, if that were true, the trial should have been stopped for efficacy a long time ago. Instead, there is a strong evidence that pseudoprogression did wreak havoc on the trial.

On the eve of long-awaited Topline data announcement, it's better not to be carried away by any unrealistic thought, even it may turn out to be true in the end. Instead, we should be focused on what is the reality and the most important thing in regard to the trial outcome: overall survivals, such as median, and more so of milestone/landmark survivals at the marks of two, three, four and five years.

2) Please refrain selves from posting anything not related to nwbo, like politics and Covid; and

3) Happy investing.

See the picture below regarding trades happened at 14:35pm for about 250,000 shares, in which 200,000 shares traded at $0.3495 per share, but it showed the price of the trade, the last transaction I assumed, was at the price of $0.3404 per share for about 2k shares. It is interesting and seemed that somebody was accumulating shares but didn't want people to know.

THE RECENT SHARE PRICE RUNNING UP IS DIFFERENT, REAL AND DESTINED!

Regardless how many posts have appeared in this board and others in any shapes and angles with any sentiments expressed, either confusion, angers or apologetics. This trend will continue, after maybe a hiccup if any on Monday, to knock loose a few shares because this stock will be in the dollars land very soon!

Who is Linda Powers? I think we should all known damn well she is a control manic who would not do any serious business with anyone with a big gun after Neil Woodford fiasco, like a well funded institution or hedge fund or the like in this treacherous development stage. So she has chosen retail investors, a 15,000 mass strong as her backing with constant carrot dangling ahead, and a few dozens of accredited investors or controllable small hedges like Bigger Capital, those who are eagerly willing to participate in funding the company as her rotary "ATM" whenever she needs a small raise to pay the never ending bills. That's the mess she has chosen and made in the past. Hopefully, last Friday's financing is the last one of this kind: eager small accredited investors, lengthy individually separate negotiation process, coercion and enticement. All have ended up with instant resentment, confusion, anger and apologetics expressed in message boards, telephone calls to company officials, and even formal complaints lodged to SEC, and you name it.

Take it or not, nothing will change that. After all, this is a company run by LP and LG who we know damn well. It is the way it has been for years. At least, you must have made your decision based on that.

NOW THE COLD TRUTH IS THAT THE COMPANY WILL DATA LOCK IN MAY, AND ANNOUNCE TOPLINE DATA BY THE END OF JUNE OR EARLY JULY. If there is significant change on the above, the company will notify the general public, according to the company.

IT IS MY STRONG BELIEF THIS TIME IT WILL BE TOTALLY DIFFERENT. NOT ONLY NOW DO WE HAVE PLENTY OF STEAM BUT ALSO A STRONG TAIL WIND -- WE MAY SOON BECOME INVESTORS OF A PARADIGM SHIFT CANCER TREATMENT PLATFORM FOR ALMOST ALL SOLID CANCERS. THAT'S THE MIGHTY POWER BEHIND!

THE TIMING IS NEAR, THE POTENTIAL IS HUGE!

Of course we may or may not see a hiccup on Monday's trading knocking free some loose shares so be prepared to make use of it if it does happen.

He meant he would bail out or indeed he has bailed out, including a few others like the lawyer, etc,. while others like me are averaging up.

Like people say it's no brainier from here, all the way up at least $1 until Topline.

After Topline data, it would be a wild west.

Only people who are active in social media about their stocks are traders, some diehard long investors, shorts, and those mentally ill, like a lot in this board who have had no positions but stick in the board like a glue.

We may break out today, or definitely after Q next week.

Before my morning stroll, here is my one post a day post:

Hi J, I think you have noticed 8-k filing today for about 1.6 million non-dilutive funding but chose not to give us a summary like you have done almost every and each time before, because this time the financing seems not up to your narrative to smear the company, which I understand.

Yes, of course there are about $150,000 OID, but the beauty is that the company is not required to repay for the next 7 months in which time we should be able to see Topline data.

Also have you noticed that the share price started taking off beginning around 20 May, the exact time of this financing date.

Coupled with about 233 millions of warrants and options, which were either expired or suspended until Nov 2020, we are in shortage of shares, resulted in the share price which has increased from around $0.17 to today's $0.345.

Make no mistake, we will continue marching higher shortly if not tomorrow.

BTW, Someone complains he/she didn't get an equally good deal as Linda and others have, but failed to understand the essence underpinned the deal, which is a significant part of reasons why share price has double since the deal is announced. As a matter of fact, those got the deal by paying little actually have a better deal than that Linda got, because now their warrants are in the money and can be exercised while Linda's much larger sums are locked until NOv. In the trading of development stage biotech companies, nobody can guarantee what is going to happen after Nov. So obviously, Linda has taken more risks.

Complains never end. First the bears, the wolfpack, then some people who think they don't have a better deals, then those who day trade, and then those who just want to buy in cheap to start a position. You get myriads of reason to complain but none will work this time around, because we have seen the light, and it's bright and beautiful.

Bright Boy you are absolutely right. MMs have failed to locate enough shares to satisfy strong demand after the last two big gap up breakaway trading days so that they had to short the stock on borrowed shares (but most likely naked short, and this time doing so is not for profit, but efforts tried to balance and locate enough shares for the strong demand).

In doing so (artificially halted the rally temporarily), they hoped more investors would sell and they would be able to collect some loosen shares, but it seems from today's trading, it is a difficult endeavour.

Now the only hope for MMs to locate cheap shares is for Linda Powers to do some stupid things; on the other hand if she can follow through regarding anticipated data lock, etc. The share price has no way to go but gap up again, again and again until up to a point where many investors are happy to unload some of their shares.

So right now, the tricks are there are forces (MMs) trying hard to pry loose shares from shareholders like retail/Bigger, etc, while there are also forces trying to get in opening up new positions, or accumulate shares. All wait for next big moves.

Linda can make things happen quickly in either direction. We shall see soon enough.

CVM is not a buy at this valuation and its MOA is not really impressive which may explain why it has failed in multiple times over more than a decade in treating other indications.

The only thing the stock has is its proactive management, and its hard-to-explained long OS with some known factors this time around.

On the other hand, nwbo is a strong buy for reasons many in this board have known, including its clear MOA and low current valuation.

Due to the suspension and expiration of massive warrants and options, nwbo now only has about 850 million fully diluted shares.

Today cvm has a valuation of 550 million while nwbo only has 226 million.

Thank you and your guys onboard nwbo train though.

[this is my only post today]

Dreaming. With the same dreaming, many have missed $0.16, $0.17, and then $0.18, and then $0.19 ...while I have been buying.

Thing has changed. A potential financing is now a nothing burger in the face of huge potential realization within a short span of time.

It's called dynamic change or change of trend. Always be aware:

Today, before market open: nwbo stock market cap: $150 million, stock price: $0.24, with both numbers trending up for many days now, even with the numbers doubled or tripled it's still unbelievably cheap.

Because, the binary event is coming by the end of June or early July following data lock by the end of this month.

Borrowed a line from somebody else, it's still not too late to get in for a huge profit, or it's never too late to get in a paradigm shift stock.

It's your money, but I just hate to see long-term investors in a sour mood when we are so close to the final realization.

What this board needs, as if I care, is a God sent psychologist to help those ever wandering to understand

Why some people say Yester's 8k is a non event? Like someone pretends to hold a long position?

And there will be no short squeeze in case with positive topline? Like a exwannabe?

And that if today's share price is not significantly higher, then the notion of short squeeze above is a bust? like a constant fliper flopper?

And a reduction of huge share counts will be no good because nobody cares, because Linda is a bad CEO? Like someone drinking Scotch?

Those people post day in and out and claims they don't have even a single share!

Lastly, if you are one of those who naked shorted with now useless warrants as hedge, what are you going to do today?

Panic to show weakness, so that everybody even a dumb cow will understand?

No, they will pretend, but the time is numbered!

It's laughable our wannebe friend thinks he can hold and carry a several dozen of millions in deficit account for six months, waiting for his future warrants to balance his ugly account. See how smart are those wolfpack hackers!

Believe or not, a huge short squeeze is coming!

Bought additional 50K today with my last buy today at $0.2002 for 10,600 shares just a few minutes ago. No done yet. If ever the share price drop for whatever reason, like pathetic financing on the eve of binary event, will buy much more.

Remember the market cap today: $151,623,746, and share price: around $0.21

Data lock: within a few days, and topline data: By then end of June or early July.

There are longs? yes, but how many? 15,000 based on 14 May registration.

In this board, a few at best. Thank God.

Does Moderna anticipate a binary event within one and one half of months, like NWBO does.

DCVax-L pivotal phase 3 trial for GBM patients will be data locked any day now and topline data will be announced by the end of June or early July.

If successful as expected, it will address a huge market demand for treating GBM patients, and it will solve the perplex question whether the underlying mechanism of action (MOA) is in effect working, proving the concept of DCVax platform for all solid cancers.

Then, what should be the price for that? Can we reach Moderna's market cap of whopping $26 billion?

What are we now in terms of nwbo stock:

Share price: a huge $0.22 per share, and market cap: a gigantic sum of about $141 million. If we were at Moderna's market cap today, nwbo stock should be trading at least more than $30 per share.

Enough said.

Stop posting anything or something about Covid-19 in this board. There are other dedicated board!

Back to nwbo, I saw many posters (or investors?) got caught up with surprise that the share price continued go higher as they anticipated a "devastated" financing, and an equally "devastated" quarterly report.

Well, as Northwest Bio is pause to usher in a new world in treating cancer, some people just don't change.

Even a dumb caw must have finally "understood" the pattern about when and how a financing deal is made, and how share price would react with that.

That's how a lot of those "smart" investors get caught up with.

The grand picture: don't pretend you are smart. We all are not, but as least we can assess risks and potential value:

Try to reconcile between a revolutionary vaccine and the underlying stock with market cap of merely $120 million, at a time the trial data is about to lucked, and topline data will be released soon after.

We all need a change of thinking or some will become added grudging pigs.

I like one or two liner too sometimes. Here you go:

If GTSM remains as leading MM for nwbo for a while, like today so far, it means a whale or two are probably behind it.

NWBO may be listed in NYSE in the near future.

[speculation of course unlike the usual one or two liner without discalimer]

Reading this board is depressed if one is serious about it. It constantly generates misinformation and illogical opinions which tends to tear down any word or statement from the company/company official. I am not talking about the wolfpack, which I despise enough to not response, but some seemingly genuine longs. In their minds anything is suspicious and the result of yet one more conspiracy.

These seemingly longs and the wolfpack forms a perfect pair we have to face in a foreseeable future.

For instance, it's nothing wrong by Les saying the top 100 patients in the trial out of a total of 331 patients lived about 5 years. He was not talking about median OS, or HR or K-M curve about the trial and patients. He was talking to a general audience in a term most would understand better, and in a limited window of a few minute time.

He said it perfectly in the radio. When the top 100 patients lived or are living in a range from 4 years up to 9 years, it's correct to say those 100 patients lived/are living about 5 year, kind of the point around which the vast majority of those 100 patients lived or are living. Is anything wrong with that? For those whose thinking is always in confusion and conspiracy, it definitely is unfortunately.

It is a promotion, yes, but a deception? no, absolutely not. If an individual in the audience invests in the company as a result of listening to Les's few-minute radio promotion without doing any further DD, he/she deserves what is to come, either rake huge profit (dumb luck) or endure more than 50% drop ("deceived by Les") depending on the outcome of the trial.

Rest your brains, LOL at increasingly useless Wolfpack posting in this board. A change is in the making which nobody can stop!

[happy about the restriction on my posting. That means no response from me]